|
| |
| | infliximab, Primary Sclerosing Cholangitis Literature |
 | | Kooros K, Katz AJ 2004 Infliximab therapy in pediatric Crohn's pouchitis. | | | Date RS, Panesar KJ, Neilly P 2004 Infliximab as a therapy for non-Crohn's enterocutaneous fistulae. | | | Chan JL, Davis-Reed L, Kimball AB 2004 Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. |
|
http://www.psc-literature.org/inflix.htm
(9900 words)
|
|
| |
| | Infliximab shows efficacy in treatment of ulcerative colitis |
| | The proportion of patients who were able to discontinue corticosteroids while in clinical remission at week 30 was significantly greater in both Infliximab groups compared with the placebo group (18 percent, 5 mg/kg; 27 percent, 10 mg/kg; 3 percent, placebo; P=0.010 and P 0.001, respectively). | | | In addition, at week 30, 52 percent of patients in the 5 mg/kg and 51 percent of patients in the 10 mg/kg Infliximab treatment group were in clinical response versus 30 percent of placebo-treated patients (P | | | Data from the ACT 1 and ACT 2 clinical trials showed Infliximab met primary and secondary endpoints of clinical response, clinical remission and mucosal healing. |
|
http://www.xagena.it/news/medicinenews_net_news/2db9f30839751e6714522e71cdad18b5.html
(935 words)
|
|
| |
| | Patient Education - Drugs - infliximab, Remicade |
| | Gastroenterologists are cautiously excited about infliximab and similar drugs that should be available in the near future. | | | It ranks drugs from A, where medical studies show no evidence for danger to the fetus or mother, to B, C, D and X, where the medical evidence indicates increasing risk to the fetus which eventually outweighs any benefit to the mother. | | | Nursing mothers should not receive this drug as its transmission in mother's milk and effect on the baby are unknown. |
|
http://www.gicare.com/pated/infliximab.htm
(849 words)
|
|
| |
| | Drugs for Arthritis -- Infliximab |
| | You will have a chest x-ray and blood tests before starting treatment and then further blood tests while you are on Infliximab to monitor its effects. | | | Is Infliximab used for any other medical conditions? | | | If you would like any further information about Infliximab, or if you have any concerns about your treatment, you should discuss this with your doctor or pharmacist. |
|
http://www.poolehos.org/rheum/infliximab.html
(746 words)
|
|
| |
| | MedlinePlus Drug Information: Infliximab (Systemic) |
| | Infliximab may cause chest pain, fever, chills, itching, hives, flushing of face, or troubled breathing within a few hours after you receive it. | | | Inactive tuberculosis infection—Should be treated before starting infliximab therapy. | | | It is important to have your heart closely checked if you take infliximab, and have existing heart disease, which could worsen while you are on infliximab therapy |
|
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203667.html
(1235 words)
|
|
| |
| | Anti-TNF for ankylosing spondylitis [December 2002; 106-2] |
| | The number needed to treat for one patient to have the outcome at 12 weeks who would not have had it if treated with placebo was 2.3 (95% confidence interval 1.6 to 3.9). | | | The number needed to treat for one patient to have the outcome at 12 weeks who would not have had it if treated with placebo was 1.4 (95% confidence interval 1.1 to 2.1). | | | Major improvement in global assessment was experienced by 17/20 patients treated with infliximab, compared with 3/20 experiencing some improvement with placebo. |
|
http://www.jr2.ox.ac.uk/bandolier/band106/b106-2.html
(1361 words)
|
|
| |
| | Infliximab for Crohn's disease - [Medication] |
| | Before starting infliximab treatment, you should be screened with a tuberculin skin test and a chest X-ray. | | | The long-term effectiveness of this drug still is being studied. | | | If the skin test is positive or the chest X-ray suggests previous exposure to TB, you will need treatment to prevent active TB. |
|
http://www.bchealthguide.org/kbase/topic/detail/drug/tw2242/detail.htm
(627 words)
|
|
| |
| | Rheumatoid arthritis - etanercept and infliximab (No. 36) |
| | A decision to continue therapy should therefore be based on how the patient’s condition is progressing and how well the drugs are working. | | | There is currently no evidence to support treatment with etanercept or infliximab for more than 4 years. | | | There is no evidence to suggest that these drugs should be used one after the other, and so this is not recommended. |
|
http://www.nice.org.uk/page.aspx?o=35993
(299 words)
|
|
| |
| | Infliximab - Wikipedia, the free encyclopedia |
| | Case studies have been done into other uses of infliximab, such as to treat skin diseases. | | | The most promise lies in those diseases that have increased amounts of TNF-alpha in the cutaneous lesions, such as psoriasis." (Gupta and Skinner, 2004 literature review article) | | | Infliximab (Remicade®) is a powerful drug used to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis. |
|
http://en.wikipedia.org/wiki/Infliximab
(326 words)
|
|
| |
| | Hospital Practice: Crohn's Disease |
| | The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease. | | | Hanauer is Professor of Medicine and Clinical Pharmacology, Section of Gastroenterology, University of Chicago Medical Center, Chicago. | | | Infliximab, a potent inhibitor of tumor necrosis factor-alpha, has been shown to be effective in inducing remission in patients refractory to other therapies. |
|
http://www.hosppract.com/issues/1999/08/dmmhan.htm
(3799 words)
|
|
| |
| | Infliximab - Drugs & Vitamins - Drug Library - DrugDigest |
| | You will receive infliximab in a clinic setting. | | | Check with your health care professional before stopping or starting any of your medicines. | | | Infliximab may worsen the symptoms of heart failure in some patients. |
|
http://www.drugdigest.org/DD/DVH/Uses/0,3915,772Infliximab,00.html
(559 words)
|
|
| |
| | Infliximab (Remicade). DermNet NZ |
| | Patients receiving infliximab require close supervision and monitoring throughout treatment. | | | Infliximab should also be used with caution in the following situations: | | | However, recent clinical trials of infliximab for the treatment of psoriasis and psoriatic arthritis are proving it to be an effective treatment for these conditions. |
|
http://www.dermnetnz.org/treatments/infliximab.html
(443 words)
|
|
| |
| | INFLIXIMAB |
| | If Infliximab is being used to treat rheumatoid arthritis, and the patient is on concomitant methotrexate therapy, providers should include the following information in block 19 of Form HCFA-1500 or the equivalent field on electronic claims: concomitant methotrexate therapy. | | | Coverage will be provided for Infliximab used in the treatment of ulcerative colitis only if the patient is severely symptomatic, to the extent that colectomy is being considered, despite aggressive conventional medical therapy (e.g., aminosylicylates, corticosteroids, etc.). | | | Infliximab is indicated in the treatment of moderately to severely active Crohn's disease for the reduction of signs and symptoms in patients who have had an inadequate response to conventional therapy; or |
|
http://www.gamedicare.com/Policies/318.1.htm
(1138 words)
|
|
| |
| | Remicade Side Effects, and Drug Interactions - Infliximab - RxList ... |
| | Additionally, the observed incidence of antibody positivity in an assay may be influenced by several factors including sample handling, timing of sample collection, concomitant medication, and underlying disease. | | | Antibody development was lower among rheumatoid arthritis and Crohn’s disease patients receiving immunosuppressant therapies such as 6-MP/AZA or MTX. | | | Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn’s disease including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates. |
|
http://www.rxlist.com/cgi/generic3/infliximab_ad.htm
(2029 words)
|
|
| |
| | Remicade infliximab side effects, tuberculosis lawyer |
| | Around 150,000 people worldwide have received Remicade (infliximab) infusions since the drug's approval in 1998. | | | Remicade (Infliximab), an immune-suppressing drug used to treat rheumatoid arthritis and Crohn's disease, has been linked to causing 70 reported cases of tuberculosis (TB) among US patients. | | | The revised labeling states that patients should be tested and treated for inactive, or latent, TB prior to infliximab therapy. |
|
http://www.remicade-side-effects.com
(265 words)
|
|
| |
| | Remicade Drug Description - Infliximab - HealthScout |
| | We subscribe to the HONcode principles of the Health On the Net Foundation | | | Infliximab binds specifically to human tumor necrosis factor alpha (TNFa) with an association constant of 1010 M-1. | | | Infliximab is produced by a recombinant cell line cultured by continuous perfusion and is purified by a series of steps that includes measures to inactivate and remove viruses. |
|
http://www.healthscout.com/rxdetail/1/118/1/main.html
(240 words)
|
|
| |
| | Infliximab |
| | 4 / 555 patients on infliximab in the Rheumatoid studies | | | In those patients who have ANF positive there is no contraindication to use. | | | However, these diseases are associated themselves with this disease and there is no direct causative association with the drug. |
|
http://www.arthritis.co.za/infliximab.html
(1040 words)
|
|
| |
| | CCFA.org: Infliximab Approved for Ulcerative Colitis |
| | The decision to use infliximab for this disease is complex and will be based on a number of factors, including a patient's response to other therapies. | | | Therefore, CCFA urges patients with colitis to discuss the risks and benefits of infliximab therapy with their IBD physician before making the decision to try the new treatment. | | | FDA Approves Infliximab (Remicade®) as the First Biologic Treatment for Ulcerative Colitis |
|
http://www.ccfa.org/about/news/infliximabforuc
(514 words)
|
|
| |
| | Infliximab |
| | Infliximab would be used in patients with severe Crohn's disease. | | | If you have an allergy to any mouse proteins, infliximab, or any other part of the medicine. | | | Infliximab will be given in a clinic or hospital setting under close observation. |
|
http://www.umm.edu/altmed/ConsDrugs/Infliximabcd.html
(659 words)
|
|
| |
| | Infliximab |
| | Infliximab is only used to reduce the inflammation of the intestines in severe Crohn& when other treatment has been ineffective. | | | It is only used when treatment with disease modifying antirheumatic drugs (DMARDs, eg sulfasalazine, methotrexate) has proved ineffective. | | | You may be given medicines such as hydrocortisone, paracetamol or an antihistamine before the infusion to prevent allergic reactions. |
|
http://www.tiscali.co.uk/lifestyle/healthfitness/health_advice/netdoctor/archive/100004617.html
(1112 words)
|
|
| |
| | Newly Approved Drug Therapies (703): Remicade (infliximab), Centocor |
| | Newly Approved Drug Therapies (703): Remicade (infliximab), Centocor | | | The most common adverse events observed in clinical trials included (but are not limited to) the following: | | | Infliximab neutralizes the biological activity of TNFa by binding with high affinity to the soluble and transmembrane forms of TNFa and inhibits binding of TNFa with its receptors. |
|
http://www.centerwatch.com/patient/drugs/dru703.html
(505 words)
|
|
| |
| | Infliximab - Product Approval Information - Licensing Action |
| | Indication for Use: Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms in patients who have an inadequate response to conventional therapies; and treatment of patients with fistulizing Crohn's disease for the reduction in the number of draining enterocutaneous fistula(s) | | | Infliximab - Product Approval Information - Licensing Action |
|
http://www.fda.gov/cder/biologics/products/inflcen082498.htm
(55 words)
|
|
| |
| | Articles - Rheumatology |
| | Most rheumatic diseases are treated with analgesics, NSAIDs (anti-inflammatory drugs), steroids (in serious cases), DMARDs ("steroid-sparing" agents) and monoclonal antibodies, such as the recently introduced infliximab and etanercept. | | | Cytology and chemical pathology of fluid aspirated from affected joints (e.g. |
|
http://www.1-electric.com/articles/Rheumatology
(192 words)
|
|
| |
| | News - FDA Approves Remicade (Infliximab) for Psoriatic Arthritis |
| | An immune-mediated inflammatory disease, psoriatic arthritis affects approximately one million men and women in the U.S. and is often characterized by the complex symptoms of joint inflammation (arthritis) and skin lesions (psoriasis). | | | MALVERN, PA -- May 17, 2005 -- Centocor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Remicade® (infliximab) to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis. | | | Click here if this is not your Personal Edition |
|
http://www.docguide.com/news/content.nsf/news/8525697700573E188525700400751ABC
(1902 words)
|
|
| |
| | FDA Grants REMICADE® (Infliximab) Fast Track Designation for Active Ulcerative Colitis |
| | Centocor, Inc, announced today that REMICADE® has received a Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the treatment of active ulcerative colitis (UC), a chronic and debilitating disease of the colon, or large intestine, that affects nearly a half million people in the United States. | | | Please send any medical news or health news press releases to: | | | FDA Grants REMICADE® (Infliximab) Fast Track Designation for Active Ulcerative Colitis |
|
http://www.medicalnewstoday.com/medicalnews.php?newsid=17983&nfid=mnf
(1125 words)
|
|
| |
| | PRESS RELEASE FDA Grants REMICADE(R) (Infliximab) Fast Track Designation for Treatment of Active Ulcerative Colitis |
| | The FDA's Fast Track regulations, based upon the FDA Modernization Act of 1997, are designed to assist in the development of products that may treat serious or life-threatening diseases and address an unmet medical need. | | | FDA Grants REMICADE(R) (Infliximab) Fast Track Designation for Treatment of Active Ulcerative Colitis | | | PRESS RELEASE FDA Grants REMICADE(R) (Infliximab) Fast Track Designation for Treatment of Active Ulcerative Colitis |
|
http://www.marketwire.com/mw/release_html_b1?release_id=77840
(1071 words)
|
|
|
